Two in vitro experiments conducted on human fibrosarcoma cells and lymphocytes confirmed this finding that STAT1 in tumor cells has a regulatory effect on the p53 pathway, demonstrating that the overexpression of STAT1 suppressed MDM2 and upregulated P53 expression [58, 59]. The gene discussed is TP53; the disease is neoplasm.